- Home
- PTCT vs TAC Comparison
PTCT vs TAC Comparison
Compare PTCT & TAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PTCT | TAC |
|---|---|---|
| Founded | 1998 | 1909 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Electric Utilities: Central |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.3B | 4.3B |
| IPO Year | 2013 | N/A |
Fundamental Metrics
Financial Performance| Metric | PTCT | TAC |
|---|---|---|
| Price | $76.81 | $12.20 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 17 | 4 |
| Target Price | ★ $73.76 | $21.63 |
| AVG Volume (30 Days) | 1.2M | ★ 1.3M |
| Earning Date | 02-26-2026 | 02-19-2026 |
| Dividend Yield | N/A | ★ 1.48% |
| EPS Growth | N/A | N/A |
| EPS | ★ 8.94 | N/A |
| Revenue | $1,779,150,000.00 | ★ $1,783,342,546.00 |
| Revenue This Year | $127.32 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $8.64 | ★ N/A |
| Revenue Growth | ★ 97.54 | N/A |
| 52 Week Low | $35.95 | $7.82 |
| 52 Week High | $87.50 | $17.88 |
Technical Indicators
Market Signals| Indicator | PTCT | TAC |
|---|---|---|
| Relative Strength Index (RSI) | 52.19 | 33.12 |
| Support Level | $74.22 | $12.62 |
| Resistance Level | $79.10 | $13.13 |
| Average True Range (ATR) | 2.12 | 0.36 |
| MACD | -0.16 | 0.02 |
| Stochastic Oscillator | 50.16 | 7.77 |
Price Performance
Historical ComparisonAbout PTCT PTC Therapeutics Inc.
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.
About TAC TransAlta Corporation
TransAlta Corp is an independent power producer based in Alberta, Canada. The company operates a diverse and growing fleet of electrical power generation assets in Canada, the United States, and Australia. The company has six reportable segments namely, Hydro, Wind & Solar, Energy Marketing, Gas, Energy Transition segment and Corporate Segment. The company generates the majority of its revenue from the gas segment.